SEC Form 4 · accession 0001520262-26-000111
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
nancy lynn snyderman M.D.
Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 3, 2026 · 7:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 3, 2026 | M | 27,948 | $46.72 | A | 43,343 | D | |
| Ordinary Shares | Aug 3, 2026 | M | 16,524 | $46.72 | A | 59,867 | D | |
| Ordinary SharesF1 | Aug 3, 2026 | S | 44,472 | $50.348 | D | 15,395 | D | |
| Ordinary SharesF2 | holding | — | — | — | 20,783 | I | By the Snyderman Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)F3 | $46.72 | Aug 3, 2026 | M | 27,948 | D | — | Sep 14, 2026 | Ordinary Shares | 27,948 | 0 | D |
| Non Qualified Stock Option (Right to Buy)F3 | $46.72 | Aug 3, 2026 | M | 16,524 | D | — | Sep 14, 2026 | Ordinary Shares | 16,524 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.07 to $50.70. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- F2Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
- F3These options are fully vested in accordance with their terms.